Rigel Pharmaceuticals (RIGL) Tops Q3 Street Views
Tweet Send to a FriendGet Alerts RIGL Hot Sheet
Price: $4.71 +1.51%
EPS Growth %: +9.4%
Financial Fact:
Total costs and expenses: 25.71M
Today's EPS Names:
ANF, DXLG, FL, More
EPS Growth %: +9.4%
Financial Fact:
Total costs and expenses: 25.71M
Today's EPS Names:
ANF, DXLG, FL, More
Trade RIGL Now!
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) reports Q3 EPS of $0.96, versus the analyst estimate of $0.62. Revenue for the quarter was $72.3 million, which compares to the estimate of $55.78 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Childrens Place (PLCE) Tops Q1 EPS by 22c; Boosts Outlook
- The Bon-Ton Stores, Inc. (BONT) Post Smaller Q1 Loss; Reaffirms Outlook
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
